Insights
Fifteen+ years of
healthcare thinking.
Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.
ESSENTIAL READING
Looking into the crystal ball – What is in store for the future of gene therapy delivery?
- By Jason Brauner and Anja Schempf
- Biopharma
Download Here: Troubleshooting GT_Recon Strategy 2022
In the last deca…
Read more
An opinionated take on NEJM highlights for June 2022
- By Marc Herant
- NEJM
A cell therapy success against a solid tumor
In CAR-T therapies, T-cel…
Read more
An opinionated take on NEJM highlights for May 2022
- By Marc Herant
- NEJM
A step forward for kidney xenotransplantation
A report on the recent, …
Read more
Advances in AI for Health in 2021: An Analysis of the Clinicaltrials.gov Registry
- By Irina Ahmad
- Digital ,
The role of artificial intelligence (AI) and machine learning (ML) in …
Read more
An opinionated take on NEJM highlights for March-April 2022
- By Marc Herant
- NEJM
The opioid crisis and patient abandonment
A perspective from a Februar…
Read more
The coming site-of-care shock for infusions
- By Jacob Wiesenthal and Tory Wolff
- Biopharma ,
- Payers ,
- Providers
There’s a major disruption looming in how the site-of-care for infusio…
Read more
The growth of small molecule drug classes over time
- By Marc Herant
- Biopharma
Modern drug discovery is largely based on the identification and valid…
Read more
An opinionated take on NEJM highlights for January-February 2021
- By Marc Herant
- NEJM
Gene therapy in beta-thalassemia and sickle cell anemia
Beta-thalassem…
Read more
Wrapping up 2021: An opinionated take on NEJM highlights for November-December 2021
- By Marc Herant
- NEJM
In search of a diagnosis: deploying genomics at scale
A substantial nu…
Read more
SELECTED ENGAGEMENTS
Insight, put to work
Our published thinking is one half of the picture. These are representative client engagements, anonymized — each tagged by sector, so you can trace the path from perspective to practice.
- Institutional
Strategy for Statewide Health Information Exchange
A non-profit health information exchange was facing financial struggles and needed a new strategy that would keep it financially sustainable
HIE, Health IT,
- Medtech, Early Stage
Growth strategy for point-of-care testing
Post pandemic an innovative diagnostics platform company wanted to dramatically increase its market by targeting retail clinics for its point-of-care diagnostics platform
Growth, product market fit, value proposition
- Institutional
University Trials
Large university wanting to dramatically increase its clinical research footprint
Keep up with Recon Strategy Insights
Get an email each time we publish a new article